Download integrale PDF - Progetto Mondiale Asma - Ginasma

145. Inhaled corticosteroids and severe viral infections.
Executive Committee. American Academy of Allergy and
Immunology.
J Allergy Clin Immunol 1993; 92: 223-8.
146. Goldstein SL, Somers MJ, Lande MB, Brewer ED,
Jabs KL. Acyclovir prophylaxis of varicella in children
with renal disease receiving steroids.
Pediatr Nephrol 2000; 14: 305-8.
147. Norris AA. Pharmacology of sodium cromoglycate.
Clin Exp Allergy 1996; 26 Suppl 4: 5-7S.
148. Diaz P, Galleguillos FR, Gonzalez MC, Pantin CF,
Kay AB. Bronchoalveolar lavage in asthma: the effect of
disodium cromoglycate (cromolyn) on leukocyte counts,
immunoglobulins, and complement.
J Allergy Clin Immunol 1984; 74: 41-8.
149. Devalia JL, Rusznak C, Abdelaziz MM, Davies RJ.
Nedocromil sodium and airway inflammation in vivo and
in vitro.
J Allergy Clin Immunol 1996; 98: S51-7.
150. Edwards AM. Sodium cromoglycate (Intal) as an antiinflammatory
agent for the treatment of chronic asthma.
Clin Exp Allergy 1994; 24: 612-23.
151. Bel EH, Timmers MC, Hermans J, Dijkman JH, Sterk PJ.
The long-term effects of nedocromil sodium and
beclomethasone dipropionate on bronchial
responsiveness to methacholine in nonatopic asthmatic
subjects.
Am Rev Respir Dis 1990; 141: 21-8.
152. Szefler SJ, Nelson HS. Alternative agents for
antiinflammatory treatment of asthma.
J Allergy Clin Immunil 1998; 102: S23-35.
153. Barnes PJ, Pauwels RA. Theophylline in the
management of asthma: time for reappraisal?
Eur Respir J 1994; 7: 579-91.
154. Kidney J, Dominguez M, Taylor PM, Rose M, Chung KF,
Barnes PJ. Immunomodulation by theophylline in
asthma. Demonstration by withdrawal of therapy.
Am J Respir Crit Care Med 1995; 151: 1907-14.
155. Sullivan P, Bekir S, Jaffar Z, Page C, Jeffery P, Costello
J. Anti-inflammatory effects of low-dose oral theophylline
in atopic asthma.
Lancet 1994; 343: 1006-8.
156. Weinberger M, Hendeles L. Theophylline in asthma.
N Engl J Med 1996; 334: 1380-8.
157. Rivington RN, Boulet LP, Cote J, Kreisman H, Small DI,
Alexander M, et al. Efficacy of Uniphyl, salbutamol, and
their combination in asthmatic patients on high-dose
inhaled steroids.
Am J Respir Crit Care Med 1995; 151: 325-32.
160 PROGRAMMA DI TRATTAMENTO DELL’ASMA IN SEI PARTI
158. Tinkelman DG, Reed CE, Nelson HS, Offord KP.
Aerosol beclomethasone dipropionate compared with
theophylline as primary treatment of chronic, mild to
moderately severe asthma in children.
Pediatrics 1993; 92: 64-77.
159. Reed CE, Offord KP, Nelson HS, Li JT, Tinkelman DG.
Aerosol beclomethasone dipropionate spray compared
with theophylline as primary treatment for chronic mildto-moderate
asthma. The American Academy of Allergy,
Asthma and Immunology Beclomethasone
Dipropionate-Theophylline Study Group.
J Allergy Clin Immunol 1998; 101: 14-23.
160. Evans DJ, Taylor DA, Zetterstrom O, Chung KF,
O’Connor BJ, Barnes PJ. A comparison of low-dose
inhaled budesonide plus theophylline and high-dose
inhaled budesonide for moderate asthma.
N Engl J Med 1997; 337: 1412-8.
161. Ukena D, Harnest U, Sakalauskas R, Magyar P, Vetter
N, Steffen H, et al. Comparison of addition of
theophylline to inhaled steroid with doubling of the dose
of inhaled steroid in asthma.
Eur Respir J 1997; 10: 2754-60.
162. Lim S, Jatakanon A, Gordon D, Macdonald C, Chung
KF, Barnes PJ. Comparison of high dose inhaled
steroids, low dose inhaled steroids plus low dose
theophylline, and low dose inhaled steroids alone in
chronic asthma in general practice.
Thorax 2000; 55: 837-41.
163. Paggiaro PL, Giannini D, Di Franco A, Testi R.
Comparison of inhaled salmeterol and individually dosetitrated
slow-release release theophylline in patients with
reversible airway obstruction.
Eur Respir J, 9: 1689-1695, 1996.
164. Davies B, Brooks G, Devoy M. The efficacy and safety of
salmeterol compared to theophylline: meta-analysis of
nine controlled studies.
Respir Med 1998; 92: 256-63.
165. Wilson AJ, Gibson PG, Coughlan J. Long acting betaagonists
versus theophylline for maintenance treatment
of asthma.
Cochrane Database Syst Rev 2000; 2.
166. Nelson HS. Beta-adrenergic bronchodilators.
N Engl J Med 1995; 333: 499-506.
167. Boulet LP. Long- versus short-acting beta 2-agonists.
Implications for drug therapy.
Drugs 1994; 47: 207-22.
168. Roberts JA, Bradding P, Britten KM, Walls AF, Wilson S,
Gratziou C, et al. The long-acting beta2-agonist
salmeterol xinafoate: effects on airway inflammation in
asthma.
Eur Respir J 1999; 14: 275-82.